Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists

Latest Column Group LLC Stock Portfolio

$160Million

Equity Portfolio Value
Last Reported on: 15 May, 2024

About Column Group LLC and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Column Group LLC reported an equity portfolio of $160.5 Millions as of 31 Mar, 2024.

The top stock holdings of Column Group LLC are TNYA, ORIC, NGM. The fund has invested 30.6% of it's portfolio in TENAYA THERAPEUTICS, INC. and 30.3% of portfolio in ORIC PHARMACEUTICALS INC.

They significantly reduced their stock positions in SURROZEN, INC. (SRZN) and ORIC PHARMACEUTICALS INC. (ORIC). Column Group LLC opened new stock positions in SAGIMET BIOSCIENCES INC..

New Buys

Ticker$ Bought
SAGIMET BIOSCIENCES INC.93,056

New stocks bought by Column Group LLC

Additions

No additions were made to existing positions by Column Group LLC

Reductions

Ticker% Reduced
SURROZEN, INC.-1.77
ORIC PHARMACEUTICALS INC.-0.77

Column Group LLC reduced stake in above stock

Sold off

None of the stocks were completely sold off by Column Group LLC

Current Stock Holdings of Column Group LLC

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
NGMNGM BIOPHARMACEUTICALS INC17.9618,136,70028,837,400UNCHANGED0.00
ORICORIC PHARMACEUTICALS INC.30.333,540,78048,685,700REDUCED-0.77
RAPTRAPT THERAPEUTICS INC14.992,680,62024,072,000UNCHANGED0.00
RVMDREVOLUTION MEDICINES INC0.0046.001,483UNCHANGED0.00
SRZNSURROZEN, INC.6.03616,5409,685,840REDUCED-1.77
TNYATENAYA THERAPEUTICS, INC.30.629,400,29049,163,500UNCHANGED0.00
SAGIMET BIOSCIENCES INC.0.0617,16993,056NEW